OTCMKTS:RCAR - RenovaCare Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $1.01 -0.09 (-8.18 %) (As of 05/24/2019 04:00 PM ET)Previous Close$1.01Today's Range$1.01 - $1.0752-Week Range$1.01 - $5.14Volume5,886 shsAverage Volume7,571 shsMarket Capitalization$88.05 millionP/E RatioN/ADividend YieldN/ABeta2.16 ProfileChartEarningsFinancialsInsider TradesHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email RenovaCare, Inc., a development-stage company, focuses on the acquisition, development, and commercialization of autologous cellular therapies for use in medical and aesthetic applications. It is developing CellMist System for spraying a patient's own skin stem cells onto burns and wounds for self-healing; and SkinGun, a solution sprayer device for delivering the cells to the treatment area. The company was formerly known as Janus Resources, Inc. and changed its name to RenovaCare, Inc. in January 2014. RenovaCare, Inc. is based in Scottsdale, Arizona. Receive RCAR News and Ratings via Email Sign-up to receive the latest news and ratings for RCAR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:RCAR Previous Symbol CUSIPN/A CIK1016708 Webhttp://www.renovacareinc.com/ Phone888-398-0202Debt Debt-to-Equity RatioN/A Current Ratio35.32 Quick Ratio35.32Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$0.17 per share Price / Book5.94Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-2,120,000.00 Net MarginsN/A Return on Equity-25.42% Return on Assets-22.83%Miscellaneous Employees1 Outstanding Shares87,176,000Market Cap$88.05 million Next Earnings Date8/8/2019 (Estimated) OptionableNot Optionable RenovaCare (OTCMKTS:RCAR) Frequently Asked Questions What is RenovaCare's stock symbol? RenovaCare trades on the OTCMKTS under the ticker symbol "RCAR." When is RenovaCare's next earnings date? RenovaCare is scheduled to release their next quarterly earnings announcement on Thursday, August 8th 2019. View Earnings Estimates for RenovaCare. Has RenovaCare been receiving favorable news coverage? News articles about RCAR stock have been trending positive on Saturday, according to InfoTrie Sentiment. The research group identifies positive and negative media coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. RenovaCare earned a news impact score of 3.0 on InfoTrie's scale. They also assigned news headlines about the biotechnology company a news buzz of 4.0 out of 10, meaning that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future. Who are some of RenovaCare's key competitors? Some companies that are related to RenovaCare include Accuray (ARAY), Inovio Pharmaceuticals (INO), Westaim (WEDXF), Utah Medical Products (UTMD), Vapotherm (VAPO), SeaSpine (SPNE), Pulse Biosciences (PLSE), Iradimed (IRMD), Neuronetics (STIM), Cytosorbents (CTSO), Apyx Medical (APYX), Alphatec (ATEC), Liquidia Technologies (LQDA), Endologix (ELGX) and iCAD (ICAD). What other stocks do shareholders of RenovaCare own? Based on aggregate information from My MarketBeat watchlists, some companies that other RenovaCare investors own include Brainstorm Cell Therapeutics (BCLI), ReNeuron Group (RENE), Advanced Micro Devices (AMD), Randgold Resources (GOLD), SCYNEXIS (SCYX), Teva Pharmaceutical Industries (TEVA), Akebia Therapeutics (AKBA), Cisco Systems (CSCO), Cypress Semiconductor (CY) and Iovance Biotherapeutics (IOVA). Who are RenovaCare's key executives? RenovaCare's management team includes the folowing people: Ms. Patsy J. Trisler, VP of Regulatory & Clinical Affairs (Age 71)Mr. Harmel S. Rayat, Founder, Chairman & CEO (Age 58)Mr. Steve Yan-Klassen, Chief Financial OfficerMr. Jatinder Singh Bhogal, Chief Operating Officer (Age 52)Mr. Andrew Danielson, Director of Operations How do I buy shares of RenovaCare? Shares of RCAR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is RenovaCare's stock price today? One share of RCAR stock can currently be purchased for approximately $1.01. How big of a company is RenovaCare? RenovaCare has a market capitalization of $88.05 million. RenovaCare employs 1 workers across the globe. What is RenovaCare's official website? The official website for RenovaCare is http://www.renovacareinc.com/. How can I contact RenovaCare? RenovaCare's mailing address is 9375 E. SHEA BLVD. SUITE 107-A, SCOTTSDALE AZ, 85260. The biotechnology company can be reached via phone at 888-398-0202. MarketBeat Community Rating for RenovaCare (OTCMKTS RCAR)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 64 (Vote Outperform)Underperform Votes: 59 (Vote Underperform)Total Votes: 123MarketBeat's community ratings are surveys of what our community members think about RenovaCare and other stocks. Vote "Outperform" if you believe RCAR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RCAR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 5/25/2019 by MarketBeat.com StaffFeatured Article: What is the Beige Book? Receive Analysts' Upgrades and Downgrades Daily Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.